Schedule 13D ownership disclosure

Anixa Biosciences Inc

Common Stock · CUSIP: 03528H109

Event date: 2025-06-04

Filing-level shares
6,173,097.00
Percent of class
16.3%
  • Amit KumarReported CIK 0001191905

    Shares: 6,173,097.00 · Class: 16.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-014126
Form type
SCHEDULE 13D/A
Filer
Anixa Biosciences Inc
CIK
CIK 715446
Filed
Jun 06, 2025
Reporting period
Jun 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub